adult-type diffuse gliomas
Showing 1 - 25 of >10,000
PRO-CTCAE for Adult-type Diffuse Gliomas Chinese Population
Not yet recruiting
- Glioma
- +3 more
-
Beijing, Beijing, China
- +16 more
Aug 4, 2022
Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 8, 2022
A Taiwanese Oncogenetic Panel and Integrated Clinical Data
Not yet recruiting
- Primary Malignant Brain Tumors
- A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma
-
Kaohsiung, Taiwan
- +8 more
Nov 22, 2022
Adult Brainstem Glioma Trial in Paris (Temozolomide)
Recruiting
- Adult Brainstem Glioma
-
Paris, FranceAPHP - Groupe Hospitalier Pitié-Salpêtrière
Sep 9, 2021
High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))
Recruiting
- High Grade Glioma
- +12 more
- LUTATHERA® (Lutetium Lu 177 dotatate)
-
Aurora, Colorado
- +8 more
Jan 16, 2023
Glioma, Malignant, Glioma Glioblastoma Multiforme Trial in Warsaw ([68Ga]Ga-PSMA-11 PET/CT)
Completed
- Glioma, Malignant
- Glioma Glioblastoma Multiforme
- [68Ga]Ga-PSMA-11 PET/CT
-
Warsaw, Mazowieckie, PolandNuclear Medicne Department Medical University of Warsaw
May 29, 2023
Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)
Recruiting
- Glioblastoma
- Adult-type Diffuse Gliomas
-
Beverly Hills, California
- +83 more
Jul 25, 2022
Glioblastoma, Diffuse Glioma Trial in Worldwide (NMS-03305293 + TMZ, Lomustine)
Recruiting
- Glioblastoma
- Diffuse Glioma
- NMS-03305293 + TMZ
- Lomustine
-
Rochester, Minnesota
- +3 more
Mar 11, 2022
Adult Brain Tumor, Adult Brain Stem Glioma, Adult Diffuse Astrocytoma Trial in Philadelphia (radiation, procedure, other)
Completed
- Adult Brain Tumor
- +11 more
- proton beam radiation therapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Dec 8, 2020
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,
Completed
- Adult Anaplastic Astrocytoma
- +8 more
- Laboratory Biomarker Analysis
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 28, 2021
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Terminated
- Adult Grade III Lymphomatoid Granulomatosis
- +116 more
- brentuximab vedotin
- +2 more
-
Chicago, Illinois
- +2 more
Aug 30, 2021
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
-
Scottsdale, Arizona
- +1 more
May 6, 2022
Chromosomal Instability in Early Diagnosis of Biliary Tract
Recruiting
- Biliary Tract Carcinoma
- The extracted DNA from bile samples will be analyzed by BileCAD to determine the level of CIN.
-
Taizhou, Zhejiang, ChinaTaizhou Hospital of Zhejiang Province
Apr 25, 2023
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Diffuse Midline Glioma, H3 K27M-Mutant Trial in Rochester (Hypofractionated Radiation Therapy, Quality-of-Life Assessment,
Recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- Hypofractionated Radiation Therapy
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Brain Tumor, Cancer Trial run by the National Cancer Institute (NCI) (Zotiraciclib)
Not yet recruiting
- Brain Tumor
- Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Adult Diffuse Glioma Based on Deep Learning
Recruiting
- Astrocytoma
- +2 more
- multi-parametric magnetic resonance imaging scan
- Pathology examination
-
Nanjing, Jiangsu, ChinaDepartment of Radiology, the Affiliated Drum Tower Hospital of N
Nov 21, 2022
Glioma, Low-grade Glioma, Low Grade Glioma of Brain Trial in Philadelphia (18F-Fluciclovine)
Not yet recruiting
- Glioma
- +4 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Oct 3, 2022
Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, High Grade Glioma Trial run by the NCI (Lenalidomide, XRT, 54-59.4 Gy)
Completed
- Diffuse Intrinsic Pontine Glioma
- +2 more
- Lenalidomide
- XRT, 54-59.4 Gy
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 30, 2021
Newly Diagnosed H3-mutated Glioma Trial in Germany (drug, biological, other)
Recruiting
- Newly Diagnosed H3-mutated Glioma
- Tecentriq 1200 MG in 20 ML Injection
- +2 more
-
Mannheim, Baden-Wuerttemberg, Germany
- +7 more
Jan 18, 2023
Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)
Completed
- Diffuse Intrinsic Pontine Glioma
- +6 more
-
Washington, District of Columbia
- +6 more
Jan 12, 2023
Glioma Trial run by the National Cancer Institute (NCI) (pre-operative abemaciclib, Device for Cerebral Fluid Dialysate
Recruiting
- Glioma
- pre-operative abemaciclib
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Glioblastoma, Diffuse Intrinsic Pontine Glioma Trial in Japan (DSP-7888)
Completed
- Glioblastoma
- Diffuse Intrinsic Pontine Glioma
-
Nagoya, Aichi, Japan
- +5 more
Apr 9, 2022
Glioma, Circulating Tumor Cell Trial in Sabadell (Liquid Biopsy)
Recruiting
- Glioma
- Circulating Tumor Cell
- Liquid Biopsy
-
Sabadell, Barcelona, SpainHospital Universitari Parc Taulí
Jul 19, 2023